{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:03:49Z","timestamp":1781067829117,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSPD2024R748"],"award-info":[{"award-number":["RSPD2024R748"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113787","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T09:48:50Z","timestamp":1733651330000},"page":"113787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The PPAR-\u03b1 selective agonist WY14643 improves lupus nephritis via the downregulation of the ROR\u03b3T\/STAT3 signaling pathway in MRL\/lpr mice"],"prefix":"10.1016","volume":"145","author":[{"given":"Haneen A.","family":"Al-Mazroua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabry M.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Bakheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushtaq A.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatun A.","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah K.","family":"Algarzae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa H.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh F.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113787_b0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2013.02.010","article-title":"Autoimmune diseases and reproductive aging","volume":"149","author":"Bove","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113787_b0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/jhg.2011.49","article-title":"Cumulative association of eight susceptibility genes with systemic lupus erythematosus in a Japanese female population","volume":"56","author":"Koga","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.intimp.2024.113787_b0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0961203311426568","article-title":"Environment and lupus-related diseases","volume":"21","author":"Zandman-Goddard","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113787_b0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113787_b0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113787_b0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bbrc.2017.08.075","article-title":"Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus","volume":"492","author":"Liu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2024.113787_b0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2007.12.003","article-title":"How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype","volume":"29","author":"Crisp\u00edn","year":"2008","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113787_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.autrev.2010.03.006","article-title":"CD8+ Tregs in lupus, autoimmunity, and beyond","volume":"9","author":"Dinesh","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2024.113787_b0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.autrev.2011.09.008","article-title":"Regulatory T cells in systemic lupus erythematosus (SLE); role of peptide tolerance","volume":"11","author":"Sawla","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2024.113787_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/096120300678828703","article-title":"Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus","volume":"9","author":"Wong","year":"2000","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.intimp.2024.113787_b0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113787_b0060","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/rheumatology\/kep255","article-title":"The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus","volume":"48","author":"Kwan","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2024.113787_b0065","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in systemic lupus erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1189\/jlb.0308149","article-title":"Interleukin 21: a cytokine\/cytokine receptor system that has come of age","volume":"84","author":"Leonard","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113787_b0075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/ard.2007.075424","article-title":"Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus","volume":"67","author":"Sawalha","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2024.113787_b0080","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1002\/art.24658","article-title":"A polymorphism within IL21R confers risk for systemic lupus erythematosus","volume":"60","author":"Webb","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.intimp.2024.113787_b0085","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.178.6.3822","article-title":"IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression","volume":"178","author":"Herber","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113787_b0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3892\/ijmm.2022.5098","article-title":"Tumor necrosis factor-\u03b1 in systemic lupus erythematosus: structure, function and therapeutic implications","volume":"49","author":"Ghorbaninezhad","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2024.113787_b0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cyto.2011.08.026","article-title":"The role of tumor necrosis factor-alpha (TNF-\u03b1) in the pathogenesis of systemic lupus erythematosus","volume":"56","author":"Postal","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2024.113787_b0100","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/art.11264","article-title":"Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus","volume":"48","author":"Svenungsson","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2024.113787_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064541","article-title":"PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings","volume":"8","author":"Puligheddu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/10409238.2015.1092944","article-title":"Macrophage-derived lipid agonists of PPAR-\u03b1 as intrinsic controllers of inflammation","volume":"51","author":"Pontis","year":"2016","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2024.113787_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/193019","article-title":"WY-14643, a potent peroxisome proliferator activator receptor-\u03b1 PPAR-\u03b1 agonist ameliorates the inflammatory process associated to experimental periodontitis","volume":"2010","author":"Briguglio","year":"2010","journal-title":"PPAR Res."},{"issue":"21","key":"10.1016\/j.intimp.2024.113787_b0120","doi-asserted-by":"crossref","first-page":"22057","DOI":"10.1074\/jbc.M402828200","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1","volume":"279","author":"Cheng","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0125","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neures.2011.02.001","article-title":"Effects of chronic systemic treatment with peroxisome proliferator-activated receptor \u03b1 activators on neuroinflammation induced by intracerebral injection of lipopolysaccharide in adult mice","volume":"70","author":"Wang","year":"2011","journal-title":"Neurosci. Res."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113787_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death inmixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113787_b0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-013-1826-0","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation protects against endoplasmic reticulum stress-induced HepG2 cell apoptosis","volume":"385","author":"Tang","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2024.113787_b0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2006.04.030","article-title":"Oxidative stress and inflammatory response evoked by transient cerebral ischemia\/reperfusion: effects of the PPAR-alpha agonist WY14643","volume":"41","author":"Collino","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.113787_b0145","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0300985810370005","article-title":"Mouse models of systemic lupus erythematosus reveal a complex pathogenesis","volume":"47","author":"Rottman","year":"2010","journal-title":"Vet. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000199","article-title":"Mouse models of lupus: what they tell us and what they don\u2019t","volume":"5","author":"Richard","year":"2018","journal-title":"Lupus Sci. Med."},{"issue":"9","key":"10.1016\/j.intimp.2024.113787_b0155","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00213-014-3802-0","article-title":"WY14643 produces anti-depressant-like effects in mice via the BDNF signaling pathway","volume":"232","author":"Jiang","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.intimp.2024.113787_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pbb.2016.12.010","article-title":"WY-14643, a selective agonist of peroxisome proliferator-activated receptor-\u03b1, ameliorates lipopolysaccharide-induced depressive-like behaviors by preventing neuroinflammation and oxido-nitrosative stress in mice","volume":"153","author":"Yang","year":"2017","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"11","key":"10.1016\/j.intimp.2024.113787_b0165","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1007\/s11064-016-2002-1","article-title":"WY14643 Attenuates the Scopolamine-Induced Memory Impairments in Mice","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.intimp.2024.113787_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/ar1879","article-title":"Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB\/W F1 mice","volume":"8","author":"Tao","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2019.07.006","article-title":"The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T+ Itpr3tf\/J mouse model of autism","volume":"152","author":"Ahmad","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113787_b0180","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.pnpbp.2017.08.002","article-title":"Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism","volume":"79","author":"Ahmad","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2024.113787_b0185","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2024.113787_b0190","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrneph.2012.220","article-title":"Diagnosis and treatment of lupus nephritis flares\u2013an update","volume":"8","author":"Sprangers","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2024.113787_b0195","doi-asserted-by":"crossref","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0200","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular regulated protein kinases signaling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0205","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113787_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2014.05.004","article-title":"Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus","volume":"154","author":"Martin","year":"2014","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113787_b0225","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crisp\u0131n","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-019-1876-0","article-title":"Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells","volume":"21","author":"Li","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0235","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/eji.200839105","article-title":"Novel therapeutic targets along the Th17 pathway","volume":"39","author":"Ouyang","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113787_b0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ncprheum0815","article-title":"Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus","volume":"4","author":"Pan","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113787_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9952463","article-title":"Circulating IL-17 level is positively associated with disease activity in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"2021","author":"Yin","year":"2021","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0250","first-page":"161","article-title":"Mechanisms of JAK\/STAT signaling in immunity and disease","volume":"368","author":"O'She","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113787_b0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of Jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113787_b0260","article-title":"Protein tyrosine phosphatases as wardens of STAT signaling","volume":"3","author":"Bohmer","year":"2014","journal-title":"JAKSTAT"},{"issue":"37","key":"10.1016\/j.intimp.2024.113787_b0265","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1073\/pnas.1408023111","article-title":"Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling","volume":"111","author":"Hedrich","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clim.2015.04.004","article-title":"Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL\/lpr mice","volume":"158","author":"Edwards","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113787_b0275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0961203306075383","article-title":"Activation of the STAT1 signalling pathway in lupus nephritis in MRL\/lpr mice","volume":"16","author":"Dong","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113787_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930601095148","article-title":"Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration","volume":"40","author":"Harada","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.113787_b0285","doi-asserted-by":"crossref","DOI":"10.1186\/ar4100","article-title":"A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis","volume":"14","author":"Liu","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0290","first-page":"172","article-title":"Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to generation of plasma B cells","volume":"31","author":"Nakou","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113787_b0295","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3899\/jrheum.120468","article-title":"Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus","volume":"39","author":"Terrier","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113787_b0300","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1073\/pnas.0807309106","article-title":"A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice","volume":"106","author":"Bubier","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2024.113787_b0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-60761-720-4_11","article-title":"A murine autoimmune model of rheumatoid arthritis and systemic lupus erythematosus associated with deregulated production of IL-17 and IL-21","volume":"900","author":"Biswas","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113787_b0310","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1535370213477597","article-title":"IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus","volume":"238","author":"Zhao","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0315","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.12330","article-title":"Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients","volume":"177","author":"Zhao","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113787_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13344-w","article-title":"Elevated levels of CCR6(+) T helper 22 cells correlate with skin and renal impairment in systemic lupus erythematosus","volume":"7","author":"Zhong","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.113787_b0325","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10875-013-9878-1","article-title":"Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus","volume":"33","author":"Yang","year":"2013","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113787_b0330","first-page":"400","article-title":"Increased interleukin-22 levels in lupus nephritis and its associated with disease severity: a study in both patients and lupus-like mice model","volume":"37","author":"Yang","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113787_b0335","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/14712598.2021.1853096","article-title":"The use of anti-TNF-alpha therapies for patients with systemic lupus erythematosus. Where are we now?","volume":"21","author":"Lorenzo-Vizcaya","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.intimp.2024.113787_b0340","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1191\/0961203302lu306rr","article-title":"Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production","volume":"11","author":"Mageed","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113787_b0345","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/rheumatology\/ket428","article-title":"The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients","volume":"53","author":"McCarthy","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2024.113787_b0350","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/gfn771","article-title":"Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study","volume":"24","author":"Lionaki","year":"2009","journal-title":"Nephrol. Dial. Transpl."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:42:56Z","timestamp":1734655376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":70,"alternative-id":["S1567576924023099"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113787","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PPAR-\u03b1 selective agonist WY14643 improves lupus nephritis via the downregulation of the ROR\u03b3T\/STAT3 signaling pathway in MRL\/lpr mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113787"}}